Importance of schedule in adriamycin/cyclophosphamide combination chemotherapy
- 1 February 1978
- journal article
- research article
- Published by Elsevier
- Vol. 14 (2) , 141-146
- https://doi.org/10.1016/0014-2964(78)90172-x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- COMBINATION CHEMOTHERAPY WITH ADRIAMYCIN (NSC-123127) AND CYCLOPHOSPHAMIDE (NSC-26271) FOR SOLID TUMORS - PHASE-2 TRIAL1976
- Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemiaBritish Journal of Cancer, 1975
- Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancerCancer, 1975
- The Metabolic Fate of CyclophosphamideDrug Metabolism Reviews, 1975
- AdriamycinAnnals of Internal Medicine, 1974
- DISCUSSION PAPER: L-ASPARAGINASE INDUCED ALTERATION OF AMETHOPTERIN (METHOTREXATE) ACTIVITY IN MOUSE LEUKEMIA L5178YAnnals of the New York Academy of Sciences, 1971
- Metabolism of cyclophosphamideCancer, 1967